Steven O'Day

Dr. Steven O’Day Discusses Innovations in Immunotherapy for Colorectal Cancer on “The Top Line” by Fierce Biotech – Agenus

Agenus shared on LinkedIn:

“Tune in to ‘The Top Line’ by Fierce Biotech! Our Chief Medical Officer, Dr. Steven O’Day, shares his insights on the latest innovations and the future of immunotherapy in colorectal cancer care.”

 

Agenus cancer cancer care colorectal cancer Fierce Biotech OncoDaily Oncology Steven O'Day